Company: RGBP
Filing Date: 2025-09-04
Form Type: CORRESP
Source: 0001641172-25-026585
Chunk: 0

Company: Regen BioPharma Inc
Filing Date: 2025-09-04
Form: CORRESP
Chunk 0
---
Via Edgar

Securities and Exchange Commission

100 F. Street, NE

Washington, D.C. 20549-7410

Attn: Tyler Howes

September 4, 2025

| Re: | Regen                                       
 BioPharma, Inc.                             
 Offering                                    
 Statement on Form 1-A Filed August 29, 2025 
 File                                        
 No.: 024-12654                              |

Dear Mr. Howes

Regen Biopharma, Inc. (the “Company”) hereby requests qualification of the above-referenced offering statement at 9:30 a.m., Eastern Time, on September 5, 2025 or as soon thereafter as is practicable.

In connection with the foregoing request, the Company hereby confirms and acknowledges that:

| 1. | should                                                                                                                                
 the Commission or the staff, acting pursuant to delegated authority, qualify the filing, it does not foreclose the Commission from    
 taking any action with respect to the filing;                                                                                         |
| 2. | the                                                                                                                                   
 action of the Commission or the staff, acting pursuant to delegated authority, in qualifying the filing, does not relieve the Company 
 from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and                                       |
| 3. | the                                                                                                                                   
 Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person   
 under the federal securities laws of the United States.                                                                               |

If you should require any additional information or clarification, please do not hesitate to contact me.

| Very         
 truly yours, |
| /s/          
 David R.Koos |
| David        
 R. Koos,     |
| Chairman     
 & CEO        |